3 Nov, 2009 in
News & Articles by
admin
Mesothelioma and Asbestos
Articles, News, and Information – newbFAQLatest
Amelia Elementary School in Cincinnati, Ohio was built in 1930 as well as has seen generations of kids come through the doors. Tearing down a school so filled of memories is bittersweet for the community residents who came out to watch, but overall, the mood was joyous as well as hopeful. The[...]
READ FULL ARTICLE »
Featured
Does anyone know if Peritoneal Mesothelioma has the same awareness color for just Mesothelioma which is Pearl? What is an adenocarcinoma? With the cancer mesothelioma, what effect does metastasis to the lymph nodes have on the patient? Why are Families that Lives have been affected by MESOTHELIOMA able to be compensated but Families of Agent Or? Is there a cure for mesothelioma?
|
ProStrakan Group has announced that the U.S. Food as well as Drug Administration (FDA) has accepted their Recent Drug Application (NDA) filing for review of Abstral. Abstral is a sublingual formulation of the opioid fentanyl that rapidly disintegrates for treatment of breakthrough cancer pain. Incase Abstral completes the U.S. approval process successfully, the drug will be marketed in the United States during the subordinate half of 2010. Approximately 376 million breakthrough cancer pain attacks occur in the United States every year. Abstral will provide a convenient, effective way for cancer patients who are already using opioid analgesics to treat their breakthrough cancer pain. For the filled story, go to PharmaLive. |
Related Posts
- U.S. mesothelioma as well as other cancer patients can be prescribed Onsolis in mid-October
- BDSI receives US patent for Onsolis as well as BEMA drug delivery platform
- Cancer pain drug Onsolis approved for take in Canada
- 75% of adult cancer patients struggle with breakthrough cancer pain
- Study finds marijuana extracts more successful in treating intractable cancer pain than THC alone
